HPV Vaccine for Teens: Protection Against Cervical Cancer & What to Expect

What Is the HPV Vaccine?

The HPV vaccine (Gardasil 9 in the U.S.) protects against 9 high-risk HPV types (16, 18, 31, 33, 45, 52, 58 – cause ~90% of cervical cancers; 6, 11 – cause 90% of genital warts). It also prevents anal, oropharyngeal, penile, vulvar, and vaginal cancers.

Schedule

• Ages 9–14: 2 doses, 6–12 months apart.
• Ages 15–26: 3 doses (0, 1–2, 6 months).
• Adults 27–45: Shared clinical decision-making; may benefit if not previously exposed.

Side Effects

• Common (mild, self-limited): Injection site pain/swelling/redness, low-grade fever, headache, fatigue, dizziness, nausea.
• Rare: Syncope (fainting) – sit/lie down 15 min post-vaccination.
• No evidence of infertility, autoimmune disorders, or chronic fatigue syndrome causation.

Why Vaccinate Early?

Best protection is before any sexual exposure. Immune response is stronger in younger adolescents. Vaccination does not encourage sexual activity (studies confirm).

Addressing Anxiety

• Explain the process honestly; use distraction, deep breathing.
• Numbing cream (lidocaine) available if needle phobia.
• Emphasize: "This shot prevents cancer."

Bottom Line

The HPV vaccine is safe, effective, and cancer-preventing. It is a routine adolescent vaccine, not optional. Talk to your pediatrician or family doctor.